Marine-Derived Compounds Targeting Topoisomerase II in Cancer Cells: A Review

Giulia Greco1, Valentina Pellicioni1, Ivan Cruz-Chamorro1,2,3

  • 1Department for Life Quality Studies, University of Bologna, Corso d'Augusto 237, 47921 Rimini, Italy.

Marine Drugs
|November 10, 2022
PubMed

Insights

Marine compounds show promise for cancer therapy by inhibiting topoisomerase II (an enzyme crucial for cell survival). Further research is needed to confirm their efficacy and safety as novel anticancer agents.

Area of Science:

  • Marine Biology
  • Pharmacology
  • Oncology

Background:

  • Cancer is a leading cause of death globally, affecting millions.
  • Topoisomerase II (an enzyme vital for cell survival) inhibition is a key cancer therapy strategy.
  • Current topoisomerase II inhibitors have limitations due to side effects, driving the search for safer alternatives.

Purpose of the Study:

  • To review marine-derived compounds with anticancer activity mediated by topoisomerase II inhibition.
  • To discuss the pharmacological potential of these natural products.
  • To identify research gaps and future directions.

Main Methods:

  • Literature review of studies on marine-derived compounds and topoisomerase II inhibition.
  • Analysis of reported mechanisms of action and pharmacological properties.
  • Evaluation of existing data on anticancer activity.

Main Results:

  • Numerous marine organisms (sponges, fungi, bacteria, ascidians) yield compounds that inhibit topoisomerase II.
  • Some compounds show promising anticancer activity through this mechanism.
  • Evidence for inhibition mechanisms varies, with some studies relying on docking interactions.

Conclusions:

  • Marine natural products represent a valuable resource for developing novel topoisomerase II inhibitors.
  • Further in vitro and in vivo studies are essential to validate efficacy and selectivity.
  • Comprehensive toxicological profiling is crucial for clinical translation of these marine compounds.

Related Concept Videos

DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
31.6K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K